Home Page
-
Vanderbilt-discovered cancer killing compound is now available through Boehringer Ingelheim open science portal opnMe
By targeting a notoriously undruggable protein found in many cancers, the discovery of BI-0474 may pave the way for new cancer treatments. Shared on opnMe.com by Boehringer Ingelheim, this innovative molecule is available for global researchers to explore new research avenues. Read MoreMay. 28, 2024
-
Treatment-resistant depression linked to body mass index: study
Genetic factors are a small but significant contributor to severe depression that does not respond to standard therapy, according to researchers at Vanderbilt University Medical Center and Massachusetts General Hospital. Read MoreMay. 24, 2024
-
Research Snapshot: Understanding protein mutations that affect gene expression
Foundational research from the Hiebert lab reveals genetic targets that can be leveraged to identify therapies that affect lymphoma cell growth. Read MoreMay. 23, 2024
-
The Triumph of Common Decency
By Chuck Sanders, vice dean of the School of Medicine Basic Sciences and professor of biochemistry Joseph Lee Heywood was acquainted with suffering. Having grown up on the New Hampshire/Massachusetts border, as a young man he made his way west to Iowa in search of opportunity. However, before things could… Read MoreMay. 20, 2024
-
School of Medicine graduates celebrate Commencement
On average, each graduating student published four scientific papers based on their graduate work. Their research appeared in highly respected journals including Nature, Cell, Human Molecular Genetics and the Proceedings of the National Academy of Sciences, according to Abigail Brown, PhD, director of the Biomedical Research Education and Training Office of Outcomes Research. Read MoreMay. 16, 2024
-
New cancer target could push new drugs into the clinic
New work by Professor of Cell and Developmental Biology Bill Tansey and colleagues has determined that a new type of inhibitor—a WINi—targets cancer cells in a novel way and suggests exploiting this pathway in future anticancer drug development efforts. Read MoreMay. 14, 2024
-
Supercomputing redesign of a COVID monoclonal antibody
One of the monoclonal antibodies in the therapeutic Evusheld has been computationally redesigned to restore its action against Omicron variants of the virus that causes COVID-19. Read MoreMay. 14, 2024
-
School of Medicine Basic Sciences Staff Spotlight: Stephen Doster
Meet Stephen Doster, associate program director of academic and educational support in Basic Sciences. Read MoreMay. 13, 2024
-
Kojetin, Waterson named Vanderbilt Innovation Ambassadors
Within the intellectual powerhouse that is Vanderbilt University and Vanderbilt University Medical Center thrives a group of doctors, engineers, computer scientists and others who also are visionaries, inventors and entrepreneurs. Several of these change-makers also donate their time and expertise through the Vanderbilt Innovation Ambassadors Program to help colleagues in their departments recognize and pursue the world-altering potential of their own ideas. Read MoreMay. 13, 2024
-
Vanderbilt joins Meharry Medical College, Fisk University in hosting Tri-Institutional Seminar series
Seminar series by biomedical scientists from across the nation brings research collaboration opportunities to trainees and students from Nashville universities. Read MoreMay. 13, 2024